The influence of parasympatholytics on the resolution of acute attacks of asthma

American Journal of Medicine

Volumn 102, Issue 1, 1997, Pages 7-13

  McFadden Jr , E R ^a,b   Ilsanadi, Nabil ^a   Strauss, Louise ^a   Galan, Gayle ^a   Dixon, Lisa ^a   McFadden, Christopher B ^a   Shoemaker, Laura ^a   Gilbert, Ileen ^a   Warren, Edward ^a   Hammonds, Terry ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE; METHYLPREDNISOLONE; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; FEMALE; HOSPITALIZATION; HUMANS; IPRATROPIUM; LENGTH OF STAY; MALE; PARASYMPATHOLYTICS; PEAK EXPIRATORY FLOW RATE; TREATMENT OUTCOME;

EID: 0342460507     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00354-3     Document Type: Article

References (36)

1. McFadden ER, Jr. Evolving concepts in the pathogenesis and management of asthma. Adv Intern Med. 1994;39:357-379.
2. Skobeloff EM, Spivey WH, McNamara RM, Greenspan L. Intravenous magnesium sulfate for the treatment of acute asthma in the Emergency Department. JAMA. 1989;262:1210-1213.
3. Green SM, Rothrouk S. Intravenous magnesium for acute asthma: failure to decrease emergency treatment duration or need for hospitalization. Ann Emerg Med. 1992;21:260-265.
4. Hargreave FE, Dolovich J, Newhouse MT. The assessment and treatment of asthma: a conference report. J Allergy Immunol. 1990;85:1098-1111.
5. National Asthma Education Program, Expert Panel Report. Executive summary: guidelines for the diagnosis and management of asthma. NHLBI NAEP, publication no. 92-3091; 1991.
6. International Consensus Report of Diagnosis and Treatment of Asthma. NHLBI, NIH, publication no. 92-3091; 1992.
7. British Thoracic Society. Guidelines on the management of asthma. Thorax. 1993;48:S1-24.
8. Fanta CH, Rossing TH, McFadden ER Jr. Emergency Room treatment of asthma: relationships among therapeutic combinations, severity of obstruction and the time course of response. Am J Med. 1982;72:416-422.
9. Rossing TH, Fanta CH, McFadden ER Jr. A controlled trial of the use of single versus combined drug therapy in the treatment of acute episodes of asthma. Am Rev Respir Dis. 1981;123:190-194.
10. Ward MJ, Fentem PH, Smith WHR, Davies D. Ipratropium bromide in acute asthma. BMJ. 1981;282:598-600.
11. Beck R, Robertson C, Galdes-Sebaldt M, Levison H. Clinical and laboratory observations: combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma. J Peds. 1985;107:605-608.
12. Ward MJ, MacFarlane JT, Davies D. A place for ipratropium bromide in the treatment of severe acute asthma. Br J Dis Chest. 1985;79:374-378.
13. Fairshter RD, Habib MP, Wilson AF. Inhaled atropine sulfate in acute asthma. Respiration. 1981;42:263-272.
14. Bryant DH. Nebulized ipratropium bromide in the treatment of acute asthma. Chest. 1985;88:24-29.
15. Rebuck AS, Chapman KR, Abboud R, et al. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airway disease in the emergency room. Am J Med. 1987;82:5964.
16. O'Driscoll BR, Horsley MG, Taylor RJ, et al. Nebulized salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet. 1989;1418-1420.
17. McFadden ER, El Sanadi N, Dixon L, et al. Protocol therapy for acute asthma: therapeutic benefits and cost savings. Am J Med. 1995;99:651-661.
18. Leiner GC, Abramowitz S, Mall M, et al. Expiratory peak flow rate. Standard values for normal subjects. Use as a clinical test of ventilatory function. Am Rev Respir Dis. 1963;88:644-651.
19. Gross NJ, Skorodin MS. Anticholinergic, antimuscarinic bronchodilators. Am Rev Respir Dis. 1984; 129:856-870.
20. Gross NJ. Ipratropium bromide. NEJM. 1988;319:486-494.
21. Leahy BC, Gomm SA, Allen SC. Comparison of nebulized salbutamol with nebulized ipratropium bromide in acute asthma. Br J Dis Chest. 1983;77:159-163.
22. Karpel JP, Appel D, Breidbart D, Fusco MJ. A comparison of atropine sulfate and metaproterenol sulfate in the emergency treatment of asthma. Am Rev Respir Dis. 1986;133:727-729.
23. Higgins RM, Stradling JR, Lane DJ. Should ipratropium bromide be added to beta-agonists in treatment of acute severe asthma? Chest. 1988;94:718-722.
24. Lew DB, Herrod HG, Crawford LV. Combination of atropine and isoetharine aerosol therapy in pediatric acute asthma. Ann Allergy. 1990;64:195-200.
25. Young GP, Freitas P. A randomized comparison of atropine and metaproterenol inhalation therapies for refractory status asthmaticus. Ann Emerg Med. 1991;20:513-519.
26. Cydulka RK, Emerman CL. Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of asthma. Ann Emerg Med. 1994;23:270-274.
27. Summers QA, Tarala R. Nebulized ipratropium in the treatment of acute asthma. Chest. 1990;97:430-434.
28. Owens M, George RB. Nebulized atropine sulfate in the treatment of acute asthma. Chest. 1991;99:1084-1087.
29. Guill MF, Maloney MF, DuRant RH. Comparison of inhaled metaproterenol, inhaled atropine sulfate, and their combination in treatment of children with acute asthma. Ann Allergy. 1987;59:367-371.
30. Fanta CH, Goldstein DG, Snapper J Jr, McFadden ER Jr. Emergency therapy of asthma: comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline. Am Rev Respir Dis. 1980;122:365-371.
31. Fischl MA, Pitchenik A, Gardner LB. An index predicting relapse and need for hospitalization in patients with acute bronchial asthma. NEJM. 1981;305:783-789.
32. Rose C, Murphey G, Schwartz JS. Performance of an index predicting the response of patients with acute bronchial asthma to intensive emergency department treatment. NEJM. 1984;310:573-576.
33. Centor RN, Yarbrough B, Wood P. Inability to predict relapse in acute asthma. NEJM. 1984;310:577-580.
34. Allen CJ, Campbell AH. Dose response of ipratropium bromide assessed by two methods. Thorax. 1980;35:137-139.
35. Gomm SA, Keaney NP, Hunt LP, et al. dose-response comparison of ipratropium bromide from a metered-dose inhaler and by jet nebulization. Thorax. 1983;38:297-301.
36. Hockley B, Johnson NM. A comparison of three high doses of ipratropium bromide in chronic asthma. Br J Dis Chest. 1985;79:379-384.